Molecular Mechanisms of New and Re-purposed Synthetic as well as Natural Bioactive Molecules Against Breast Cancer: Elucidating Targets, Signaling Pathways, Resistance Modulation, and Synergistic Combinations for Prevention

Current Molecular Medicine · Published 2026-05-08 · DOI 10.2174/0115665240440305260306055108

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0115665240440305260306055108

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Dynamic Changes of Extracellular Matrix in Sepsis: A Review · Current Molecular Medicine · 2026 · Same journal
• Sodium Ion Channel Active Agent Deltamethrin Induces Cell Apoptosis and Cell Cycle Arrest through Mitochondrial Dependent Pathway in Human Fetal Lung Fibroblasts · Current Molecular Medicine · 2026 · Same journal
• Metabolite-Based Biomarkers for Autism Spectrum Disorder: Current Research Progress · Current Molecular Medicine · 2026 · Same journal
• Development of Integrated Turbidity SpectrophotometricBiosensor System with Osmotic Fragility/DichlorophenolIndophenol Precipitation Assays for Thalassemia Red Blood CellScreening · Current Molecular Medicine · 2026 · Same journal
• The Role of suPAR in Kidney Injury Progression · Current Molecular Medicine · 2026 · Same journal
• The Mutational Landscape of Angiosarcoma: Challenges andOpportunities to Design Management Strategies · Current Molecular Medicine · 2026 · Same journal
• Single-cell Sequencing Reveals Key Biological Insights into Intervertebral Disc Development and Degeneration · Current Molecular Medicine · 2026 · Same journal
• Dynamic Expression of Fibroblast Activation Protein (FAP) During Chronic Pancreatitis (CP) Progression in Mice and Evaluation of FAP-targeted Tracers for Early CP Diagnosis · Current Molecular Medicine · 2026 · Same journal
• Identification and Validation of Hub Ferroptosis‑Related Genes inSepsis: An Integrated Bioinformatics and Experimental Study · Current Molecular Medicine · 2026 · Same journal
• Integrated Histopathological and Molecular Classification of Breast Cancer Using Immunohistochemistry (ER, PR, HER2) and KI-67 · Current Molecular Medicine · 2026 · Same journal